Articles with public access mandates - Akinori URUHA（漆葉章典）Learn more
Available somewhere: 6
Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial
O Benveniste, JY Hogrel, L Belin, M Annoussamy, D Bachasson, ...
The Lancet Rheumatology 3 (1), e40-e48, 2021
Mandates: National Institute of Health and Medical Research, France
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis
C Preuße, B Paesler, C Nelke, D Cengiz, T Müntefering, A Roos, ...
Acta Neuropathologica 144 (2), 353-372, 2022
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies
M Graf, SL von Stuckrad, A Uruha, J Klotsche, L Zorn-Pauly, ...
RMD open 8 (1), e001934, 2022
Mandates: German Research Foundation
Successful plasmapheresis and immunoglobulin treatment for severe lipid storage myopathy: doing the right thing for the wrong reason
F Kleefeld, A Renesse, C Dittmayer, L Harms, J Radke, H Radbruch, ...
Neuropathology and Applied Neurobiology 48, 2021
Mandates: German Research Foundation
SIGLEC1 enables straightforward assessment of type I interferon activity in inflammatory myopathies
M Graf, SL von Stuckrad, A Uruha, J Klotsche, L Zorn-Pauly, ...
medRxiv, 2021.09. 13.21263325, 2021
Mandates: German Research Foundation
Morphological characteristics of the transition from juvenile to adult dermatomyositis
C Dittmayer, W Stenzel, HH Goebel, M Krusche, U Schneider, A Uruha, ...
Neuropathology and Applied Neurobiology 46, 790-794, 2020
Mandates: German Research Foundation
Publication and funding information is determined automatically by a computer program